Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse

Author： Jain Preetesh   Kantarjian Hagop   Patel Keyur   Faderl Stefan   Garcia-Manero Guillermo   Benjamini Ohad   Borthakur Gautam   Pemmaraju Naveen   Kadia Tapan   Daver Naval   Nazha Aziz   Luthra Raja   Pierce Sherry   Cortes Jorge   Ravandi Farhad  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1337-1344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Novel NPM1 mutation in the 3’-untranslated region identified in two patients with acute myeloid leukemia

By Abraham Ajay   Karathedath Sreeja   Kumaraswamy Vinodhini   Jayavelu Ashok Kumar   Mani Sathya   Srivastava Vivi M.   Zhang Wei   Zhou Tong   George Biju   Srivastava Alok   Mathews Vikram   Balasubramanian Poonkuzhali  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1421-1424

Informa Healthcare

Access to resources Recommend Favorite

In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

By Üstün C.   Beksac M.   Dalva K.   Koc H.   Konuk N.   Ilhan O.   Özcan M.   Topcuoglu P.   Sertkaya D.   Hayran M.  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 59-67

Humana Press, Inc

Access to resources Recommend Favorite

ASXL1 mutations are infrequent in young patients with primary acute myeloid leukemia and their detection has a limited role in therapeutic risk stratification

By El-Sharkawi Dima   Ali Akbar   Evans Catherine M.   Hills Robert K.   Burnett Alan K.   Linch David C.   Gale Rosemary E.  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1326-1331

Informa Healthcare

Access to resources Recommend Favorite

Case series of patients with acute myeloid leukemia receiving hypomethylation therapy and retrospectively found to have IDH1 or IDH2 mutations

By Benton Christopher B.   Ravandi Farhad   Andreeff Michael   Kadia Tapan   Ruvolo Vivian   Qiu Peng   Wheeler David A.   Garcia-Manero Guillermo   Cortes Jorge   Kantarjian Hagop M.   Konopleva Marina  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1431-1434

Informa Healthcare

Access to resources Recommend Favorite

Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 129-133

Spandidos Publications

Access to resources Recommend Favorite